ARCUTIS BIOTHERAPEUTICS INC (ARQT) Stock Cash Flow
NASDAQ:ARQT - Nasdaq - US03969K1088 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -129.72M | -140.04M | -262.14M | -311.46M | -206.36M | |||
| Depreciation Amortization | 5.37M | 2.60M | 1.52M | 930.00K | 450.00K | |||
| Change In Working Capital | -27.32M | -15.08M | -23.50M | -10.18M | 3.62M | |||
| Interest Paid | 18.27M | 22.21M | 25.45M | 12.64M | 140.00K | |||
| Other non cash items | 40.73M | 40.36M | 37.06M | 62.98M | 27.66M | |||
| OPERATING CASH FLOW | -110.94M | -112.16M | -247.06M | -257.72M | -174.63M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -5.75M | -5.14M | -428.00K | -23.28M | -1.00M | |||
| Other Investing Activity | 75.02M | 33.96M | 180.66M | -63.92M | -74.96M | |||
| INVESTING CASH FLOW | 69.27M | 28.82M | 180.23M | -87.20M | -75.95M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -100.00M | 0.00 | 125.00M | 73.99M | |||
| Stock Issued/Repurchased | 4.83M | 166.20M | 101.32M | 178.99M | 209.60M | |||
| Other Financing Activity | N/A | 0.00 | 0.00 | -2.19M | -1.64M | |||
| FINANCING CASH FLOW | -95.17M | 66.20M | 101.32M | 301.80M | 281.95M | |||
| Exchange Rate Effect | -158.00K | -235.00K | -50.00K | N/A | N/A | |||
| CHANGE IN CASH | -136.99M | -17.37M | 34.45M | -43.12M | 31.37M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -110.94M | -112.16M | -247.06M | -257.72M | -174.63M | |||
| Capital Expenditure | -5.75M | -5.14M | -428.00K | -23.28M | -1.00M | |||
| FREE CASH FLOW | -116.69M | -117.30M | -247.49M | -281.00M | -175.63M | |||
All data in USD